DeepMed Research

PACIRA PHARMACEUTICALS, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device

Not Applicable

Completed

Conditions: Upper Limb Spasticity

Interventions: Device: Treatment with Cryo-Touch III device

First Posted Date: 2013-05-29

Last Posted Date: 2024-01-24

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 19

Registration Number: NCT01863901

Locations: 🇺🇸
Kansas City Bone and Joint Clinic, Overland Park, Kansas, United States
🇺🇸
Dr. Mitchell Paulin, Paoli, Pennsylvania, United States

Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device

Completed

Conditions: Frown Lines
Glabellar Frown Lines

Interventions: Device: Treatment with CryoTouch III Device

First Posted Date: 2013-03-11

Last Posted Date: 2015-03-24

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 17

Registration Number: NCT01808742

Locations: 🇺🇸
77 Plastic Surgery, San Francisco, California, United States

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Phase 3

Completed

Conditions: Posterolateral Thoracotomy
Postoperative Pain

Interventions: Drug: EXPAREL 266 mg
Drug: Placebo

First Posted Date: 2013-03-01

Last Posted Date: 2021-07-12

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 191

Registration Number: NCT01802411

Locations: 🇺🇸
Louisiana State University Health Sciences Center - Shreveport, 1501 Kings Hwy, Shreveport, Louisiana, United States
🇺🇸
UT Southwestern Medical Center, Dept. Cardiovas7726cular & Thoracic Surgery, 5909 Harry Hines Blvd., 9th Fl., Dallas, Texas, United States
🇺🇸
The Methodist Hospital UANEU25, Department of Cardiovascular Surgery, 6550 Fannin, Suite 1401, Houston, Texas, United States

and more 18 locations

A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device

Completed

Conditions: Frown Lines
Glabellar Frown Lines

Interventions: Device: Treatment with CryoTouch IV

First Posted Date: 2013-03-01

Last Posted Date: 2015-03-24

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 61

Registration Number: NCT01801826

Locations: 🇺🇸
Beverly Hills International Center for Aesthetic Surgery, Beverly Hills, California, United States
🇺🇸
77 Plastic Surgery, San Francisco, California, United States

EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair

Phase 4

Completed

Conditions: Hernia

Interventions: Drug: EXPAREL

First Posted Date: 2013-02-28

Last Posted Date: 2021-03-08

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 13

Registration Number: NCT01801124

Locations: 🇺🇸
Maimonides Medical Center, Brooklyn, New York, United States

Study Evaluating Treatment of Forefoot Pain Related to Nerve Entrapment Using the Cryo-Touch III Device

Not Applicable

Completed

Conditions: Entrapment Neuropathy

Interventions: Device: Cryo-Touch III Device

First Posted Date: 2012-12-20

Last Posted Date: 2014-01-29

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 7

Registration Number: NCT01753778

Locations: 🇺🇸
SOAR Medical Group, Redwood City, California, United States
🇺🇸
International Clinical Research, Overland Park, Kansas, United States

Study Evaluating the Treatment of Occipital Neuralgia

Not Applicable

Completed

Conditions: Occipital Neuralgia

First Posted Date: 2012-12-20

Last Posted Date: 2024-01-24

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 26

Registration Number: NCT01753765

Locations: 🇺🇸
International Clinical Research, Overland Park, Kansas, United States
🇺🇸
Injury Care Medical Center, Boise, Idaho, United States
🇺🇸
Neurovations, Napa, California, United States

A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device

Not Applicable

Completed

Conditions: Osteoarthritis of the Knee

Interventions: Device: Cryo-Touch III

First Posted Date: 2012-10-11

Last Posted Date: 2024-01-24

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 33

Registration Number: NCT01704157

Locations: 🇺🇸
Injury Care Medical Center, Boise, Idaho, United States
🇺🇸
Neurovations, Napa, California, United States

Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty

Phase 2

Completed

Conditions: Postoperative Pain

Interventions: Drug: EXPAREL 67 mg
Drug: EXPAREL 266 mg
Drug: Placebo
Drug: EXPAREL 133 mg

First Posted Date: 2012-09-11

Last Posted Date: 2020-12-09

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 297

Registration Number: NCT01683071

Locations: 🇺🇸
ALLIANCE RESEARCH CENTERS 24411 Health Center Drive Suite 350, Laguna Hills, California, United States
🇺🇸
CLEVELAND CLINIC FAIRVIEW HOSPTIAL 1801 Lorain Avenue, Cleveland, Ohio, United States
🇺🇸
PENSACOLA RESEARCH CONSULTANTS,INC 5149 N.9th Avenue Suite 241, Pensacola, Florida, United States

and more 27 locations

Probe Configuration and Time-Temperature Dose Ranging for Understanding of Skin Lesion Effects

Not Applicable

Completed

Conditions: Histological Response of Tissue to Cold

Interventions: Device: Cryo-Touch III

First Posted Date: 2012-09-10

Last Posted Date: 2024-01-24

Lead Sponsor: Pacira Pharmaceuticals, Inc

Target Recruit Count: 30

Registration Number: NCT01681745

Locations: 🇺🇸
77 Plastic Surgery, San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy